MTA3 and cancer: However, scarce experimental evidence allows us to explain the expression of the SOX2‐OT/SOX2 axis in cancer, which has been recently reported to be genetic/epigenetically regulated through MTA3 and GATA3, probably in a NurD (chromatin remodeling complex) interaction, affecting cancer stemness and metastasis.